Capecitabine
Cat. No.：YN270415
| 产品名称: | Capecitabine |
| CAS No.: | 154361-50-9 |
| Chemical Name: | 5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-cytidine |
| Synonyms: | 卡培他滨 |
| 分子量: | 359.35 |
| 分子式: | C₁₅H₂₂FN₃O₆ |
| SMILES: | C[C@@H]1[C@H]([C@H]([C@H](N2C(N=C(C(F)=C2)NC(OCCCCC)=O)=O)O1)O)O |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Capecitabine 是一种可用于口服的前药，可由胸苷磷酸化酶催化转变为其活性代谢物 Fluorouracil (FU)。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Miwa, M., Ura, M., Nishida, M., et al.Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissueEur. J. Cancer34(8),1274-1281(1998)
